EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

FGF–FGFR Signaling in Parkinson’s Disease: Mechanistic Links to Ferroptosis and Neuroprotection

Hui Wang iD, Xiao Wen, Min Yan, Ran Li iD, Dewei Mao, Xuewen Tian iD

Brain Sciences · 29.01.2026 · 16 (2) · 151

DOI: 10.3390/brainsci16020151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 29.01.2026. Verfasst von Hui Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Sports Sciences, Shandong Sport University, Jinan 250102, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Program of China, TaiShan Scholars, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is characterized by progressive degeneration of the nigrostriatal dopaminergic system and α-synuclein (α-syn) pathology, with disease progression driven by convergent mechanisms including neuroinflammation, mitochondrial injury, oxidative stress, and regulated cell-death programs such as ferroptosis. Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) constitute a key signaling system in the central nervous system, influencing not only neuronal survival and glial states but also intersecting with networks governing redox homeostasis and iron metabolism. Accumulating evidence indicates that, beyond classical neurotrophic actions, FGF–FGFR signaling can modulate mitochondrial quality control, glial inflammatory activation, and lipid peroxidation-related processes, thereby reshaping cellular susceptibility to ferroptotic injury. This review summarizes current advances in understanding FGF signaling networks in Parkinson’s disease, synthesizes their potential mechanistic links to the interplay among neuroinflammation, mitochondrial dysfunction, and redox imbalance as well as to ferroptosis regulation, and discusses the experimental basis and translational challenges of targeting the FGF pathway as a disease-modifying therapeutic strategy.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseaseferroptosisfibroblast growth factorsneurodegenerative diseasesneuroinflammationoxidative stress

Autor:innen und Institutionen

  • Academy of Sports Sciences, Shandong Sport University, Jinan 250102, China.
  • Physical Education Unit, The Chinese University of Hong Kong, Shenzhen 518172, China.

ORCID-Profile: Hui Wang, Ran Li, Xuewen Tian

Förderung

  • the National Key R&D Program of China
  • TaiShan Scholars
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Shandong Provincial Sports and Fitness Technology Innovation Center

Zitieren

APA

Wang, H., Wen, X., Yan, M., Li, R., Mao, D., & Tian, X. (2026). FGF–FGFR Signaling in Parkinson’s Disease: Mechanistic Links to Ferroptosis and Neuroprotection. Brain Sciences, 16(2), 151. https://doi.org/10.3390/brainsci16020151

Vancouver

Wang H, Wen X, Yan M, Li R, Mao D, Tian X. FGF–FGFR Signaling in Parkinson’s Disease: Mechanistic Links to Ferroptosis and Neuroprotection. Brain Sciences. 2026;16(2):151. doi:10.3390/brainsci16020151

BibTeX
@article{Wang2026,
  author = {Wang, Hui and Wen, Xiao and Yan, Min and Li, Ran and Mao, Dewei and Tian, Xuewen},
  title = {FGF–FGFR Signaling in Parkinson’s Disease: Mechanistic Links to Ferroptosis and Neuroprotection},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {151},
  doi = {10.3390/brainsci16020151}
}
Kostenlos starten →